Beclin-1 targeting for inhibiting autophagy in melanoma cells has been shown to result in recruitment of natural killer (NK) cells in the tumor bed via C-C motif chemokine ligand 5 (CCL5) induction, thereby leading to tumor growth suppression [10,11,12]. The gene discussed is CCL5; the disease is neoplasm.